Philadelphia University + Thomas Jefferson University
Sidney Kimmel Medical College
Department of Medicine

Dasqupta, Indranil

< Back

Profile

ixd197

Indranil Dasgupta, MD, FACC, FACP, FAHA

Contact Dr. Dasgupta

925 Chestnut Street
Mezzanine Level
Philadelphia, PA 19107

(215) 955-4260
(215) 503-3976 fax

Medical School

St. George's University Medical School, Grenada - 1994

Residency

Medical College of Pennsylvania (MCP)
Hahnemann University Hospital

Fellowship

Hahnemann University Hospital
Robert Wood Johnson University Hospital

Board Certification

Internal Medicine
Cardiovascular Disease
Diplomate of the ACPE

Hospital Appointment

Thomas Jefferson University Hospital

Publications

Most Recent Peer-Reviewed Publications

  1. A randomized controlled crossover trial evaluating differential responses to antihypertensive drugs (used as mono- or dual therapy) on the basis of ethnicity: The comparIsoN oF Optimal Hypertension RegiMens; part of the Ancestry Informative Markers in HYpertension program—AIM-HY INFORM trial
  2. Validating the use of bioimpedance spectroscopy for assessment of fluid status in children
  3. Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease
  4. Cognitive Function Declines Significantly during Haemodialysis in a Majority of Patients: A Call for Further Research
  5. Phase II randomized sham-controlled study of renal denervation for individuals with uncontrolled hypertension-WAVE IV
  6. DOPPS data suggest a possible survival benefit of renin angiotensin-aldosterone system inhibitors and other antihypertensive medications for hemodialysis patients
  7. Application of a Nanotechnology-based, Point-of-Care Diagnostic Device in Diabetic Kidney Disease
  8. Review: In diabetes, intensive and standard glycemic control do not differ for end-stage kidney disease or death
  9. Rationale and design of BISTRO: A randomized controlled trial to determine whether bioimpedance spectroscopy-guided fluid management maintains residual kidney function in incident haemodialysis patients
  10. Phosphate Binders and Mortality: There Is a Need for More Evidence
  11. Renal denervation
  12. Response to Kinnell letter
  13. Association of British clinical diabetologists (ABCD) and renal association clinical guidelines: Hypertension management and renin-angiotensin-aldosterone system blockade in patients with diabetes, nephropathy and/or chronic kidney disease summary of recommendations
  14. Health-related quality of life impacts mortality but not progression to end-stage renal disease in pre-dialysis chronic kidney disease: A prospective observational study
  15. Prevalence and determinants of white coat effect in a large UK hypertension clinic population
  16. Renal Denervation in Patients With Uncontrolled Hypertension and Confirmed Adherence to Antihypertensive Medications
  17. Renal artery sympathetic denervation: observations from the UK experience
  18. Serum tryptase concentration and progression to end-stage renal disease
  19. Cognitive impairment in hemodialysis patients: What can slow this decline?
  20. UK National Survey of Practice Patterns of Fluid Volume Management in Haemodialysis Patients: A Need for Evidence